Blood

923 papers64 directions
Blood is a long-standing publication venue for hematological research, with active contributions in the corpus spanning from 1973 through 2026. In the context of machine learning and artificial intelligence, the venue focuses on the integration of computational methods with clinical hematology to improve patient outcomes. Its content frequently addresses the development of independent biomarkers for disease prognosis, risk stratification for precision treatment selection, and the identification of molecular regulatory axes to overcome chemotherapy resistance. The venue publishes research on the application of AI-based diagnostic tools, such as those used for identifying myelodysplastic syndromes, and the use of integrated profiling to predict treatment responses in conditions like acute myeloid leukemia. Recent papers also explore technical frameworks for data science in medicine, including the generation of synthetic data over federated learning systems to accelerate personalized medicine. This research often utilizes large-scale data sources, such as nationwide electronic health record databases, to conduct epidemiological studies on conditions like venous thromboembolism. In the broader research community, Blood serves as a platform for addressing the statistical and methodological challenges of applying data science to specialized medicine. This includes investigating the generalizability gap in single-center clinical research and managing statistical power challenges in rare disease studies. Prolific contributors such as Zhixiang Shen, Aaron D. Schimmer, and Véronique Voisin highlight the venue's role in bridging bridging strategies for stem cell transplantation with advanced predictive modeling and microvascular visualization techniques.

Papers by Year

2026 4
2025 99
2024 129
2023 83
2022 72
2021 31
2020 44
2019 40
2018 42
2017 17
2016 30
2015 30
2014 26
2013 30
2012 33
2011 32
2010 24
2009 31
2008 25
2007 13
2006 17
2005 22
2004 15
2003 6
2002 4
2001 8
2000 1
1999 2
1998 2
1997 4
1996 1
1995 1
1993 1
1990 4
1988 1
1987 1
1974 1
1973 1

Top Research Directions

Research directions most represented by papers from this venue.

Viscoelastic Monitoring of Whole Blood Coagulation 2
The Non-Additive Toxicity of Multi-Modal Adjunctive Therapies 2
Targeting the Mechanisms of Cancer Stem Cell Resistance 2
Overcoming Data Scarcity in Rare Disease Research 2
Transcriptional Artifacts and Selective Loss from Tissue Dissociation 1
Quantifying Clinical Relevance Beyond Statistical Significance 1
Molecular Clonal Tracking via Immune Repertoire Sequencing 1
Discovering Driver Pathways via Mutational Mutual Exclusivity 1
The Structural Convergence of Adaptive Immune Repertoires 1
Predicting Therapeutic Efficacy Before Morphological Change 1
Synergistic Innate Immune Activation via Combinatorial Adjuvants 1
Genetic Lineage Tracing for Mapping Cellular Ancestry 1
Mechanisms of Metabolic Drug-Drug Interactions 1
Bioorthogonal Labeling and Chemical Proteomics for Target Identification 1
The Dynamics of Dose Dependent Therapeutic Efficacy 1

Top Authors

AuthorPapers
Zhixiang Shen38
Jane E. Barker19
Hongyu An15
Barbara D. Lam12
Zinaida Good12
Mikel Hernaez11
Bita Sahaf9
Lori Muffly9
Matthew J. Frank9
James Nichols8
Jorge J. Nieva8
Allon M Klein7
Filippo Utro6
Jianqiang Li6
Kahn Rhrissorrakrai6
Meong Hi Son6
Moksha H. Desai6
Saurabh Dahiya6
Zachary Ehlinger6
Andrew R. Rezvani5

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Monocyte activation state regulates monocyte-induced endothelial proliferation through Met signaling2010
New Cases of Acute Promyelocytic Leukemia Treatment by Arsenic Trioxide Alone and Their Long Term Follow up2010
Prevalence of Venous Thromboembolism In Patients with Secondary Polycythemia2010
Quantitative Whole Genome Analysis of Sequential Samples From Patients with B-CLL Identifies Novel Recurrent Copy Number Alterations Involving Critical B-Cell Transcription Factors2010
Rituximab Plus Three Cycles of Dexamethasone In the Treatment of Immune Thrombocytopenia (ITP): a Pilot Study.2010
Role of Polycomb Repressive Complex 1 (PRC1) In Runx1 Mediated Gene Regulation2010
Subject Index Vol. 30, 20102010
Superior Outcome Using Cyclosporin A Alone Versus Cyclosporin A Plus Methotrexate for Post-Transplant Immunosuppression In Children with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantati2010
Synergy Between Kit Ligand (KL) and IL-4 In Mast Cells Is Mediated by Cross-Receptor Interactions In Lipid Rafts.2010
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells2010
The management of recurrent VTE in cancer patients receiving therapeutic anticoagulation: the use of dual anticoagulant therapy combined with an IVC filter2010
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma2010
Accuracy of automated oscillometric blood pressure monitors in the detection of cardiac arrhythmias2009
Activation of Chloride Channels with the Anti-Parasitic Agent Ivermectin Induces Membrane Hyperpolarization and Cell Death in Leukemia Cells.2009
A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster2009
A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients2009
Arsenic Trioxide as First Line Therapy for New Case of APL, Results and Long Term Follow up.2009
A Small Molecule Inhibitor of D-Cyclin Transactivation Displays Preclinical Efficacy in Myeloma and Leukemia.2009
A Worldwide Observational Registry Collecting Longitudinal Data On the Management of CML Patients (The WORLD CML Registry) - Summary of the First 1001 Patients.2009
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells2009
Coordinated Regulation of Hematopoietic and Mesenchymal Stem Cells in a Bone Marrow Niche.2009
Cytogenetic and Molecular Features of 1331 Chinese Patients with Primary Acute Lymphoblastic Leukemia (ALL).2009
Distance From a Tertiary Care Center Is Not a Barrier to Transplant for Patients with Myeloma.2009
Distribution of KIR2DS4 Alleles in Chinese Han Population and the Impact of KIR2DS4 Alleles On the Development of Acute Gvhd Post Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.2009
Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -;Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Acce2009
Eμ-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-κB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma2009
Impact of Prior Therapy and Suboptimal Response to Imatinib On the Efficacy and Safety of Nilotinib Among 1,422 Patients with Imatinib-Resistant or —Intolerant Chronic Myeloid Leukemia (CML) in Chroni2009
Is lowering blood pressure hazardous in patients with significant ipsilateral carotid stenosis and acute ischaemic stroke? Interim assessment in the ‘Efficacy of Nitric Oxide in Stroke’ Trial2009
Long-Term Outcome of Imatinib Treatment in Chronic Myeloid Leukemia (CML) Patients in Shanghai: An International Patient Assistance Programs (GIPAP) Analysis.2009
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification2009
Molecular profiling of CD3−CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways2009
Over-Expression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes.2009
P15 and P16 Promoters Methylation Status in APL Patients Treated by Arsenic Trioxide.2009
Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials2009
Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression2009
Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose2009
Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.2009
Subject Index Vol. 28, 20092009
Survival Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) and Imatinib in the Treatment of Chronic Myeloid Leukemia Treatment in China: a Meta-Analysis.2009
The Hematopoietic Stem Cell Niche.2009
The Novel Proteasome Inhibitor 5-Amino-8-Hydroxyquinole (5AHQ) Overcomes Bortezomib Resistance in Malignant Hematological Cell Line Models Harboring Mutations in the PSMB5 Gene.2009
TLR4 Asp299Gly Variant Confers Strong Protection against BK Virus-Associated Hemorrhagic Cystitis After Hematopoietic Stem Cell Transplantation in Children.2009
Wiskott-Aldrich syndrome protein is an effector of Kit signaling2009
Age-Related Perturbation of Thymic Epithelial Cells (TEC) Homeostasis Is Caused by Increased TNFR/Fas-Mediated Apoptosis Coupled with Decreased Proliferation2008
Agonist and Antagonist Effects of Diadenosine Tetraphosphate, a Platelet Dense Granule Constituent, on Platelet P2Y1, P2Y12 and P2X1 Receptors2008
A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction2008
A Multicentre, Randomized Study of FLAG Treatment in China(CHORT).2008
A Novel Chromene-Based Pan-PI3 Kinase Inhibitor Displays Preclinical Activity in Leukemia and Myeloma.2008
A Novel Non-Competitive Chemical Proteasome Inhibitor Displays Preclinical Activity in Myeloma and Leukemia.2008
A Retrospective Study of Introferon-Alpha Treatment on Chinese Patients with Chronic Myeloid Leukemia2008

« prev Page 16/19 next »